| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Neuropeptide Y receptor type 5 |
|---|
| Ligand | BDBM50268739 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_523817 (CHEMBL1008329) |
|---|
| IC50 | 0.69±n/a nM |
|---|
| Citation |  Takahashi, T; Haga, Y; Sakamoto, T; Moriya, M; Okamoto, O; Nonoshita, K; Shibata, T; Suga, T; Takahashi, H; Hirohashi, T; Sakuraba, A; Gomori, A; Iwaasa, H; Ohe, T; Ishihara, A; Ishii, Y; Kanatani, A; Fukami, T Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. Bioorg Med Chem Lett19:3511-6 (2009) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Neuropeptide Y receptor type 5 |
|---|
| Name: | Neuropeptide Y receptor type 5 |
|---|
| Synonyms: | NPY-Y5 | NPY-Y5 receptor | NPY5-R | NPY5R | NPY5R_HUMAN | NPYR5 | NPYY5 | Neuropeptide Y receptor type 5 | Neuropeptide Y receptor type 5 ( NPY Y5) | Y5 receptor |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 50746.64 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q15761 |
|---|
| Residue: | 445 |
|---|
| Sequence: | MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM
|
|
|
|---|
| BDBM50268739 |
|---|
| n/a |
|---|
| Name | BDBM50268739 |
|---|
| Synonyms: | CHEMBL524085 | N-(3-(4-chlorophenyl)isoxazol-5-yl)-3-oxo-3H-spiro[isobenzofuran-1,4'-piperidine]-1'-carboxamide |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H18ClN3O4 |
|---|
| Mol. Mass. | 423.849 |
|---|
| SMILES | Clc1ccc(cc1)-c1cc(NC(=O)N2CCC3(CC2)OC(=O)c2ccccc32)on1 |
|---|
| Structure | 
|
|---|
Search and Browse
